Literature DB >> 15088145

Non-Leydig sex-cord tumors of the testis. The place of immunohistochemistry in diagnosis and prognosis. A study of twenty cases.

Eva Compérat1, Fréderique Tissier, Karine Boyé, Gonzague De Pinieux, Annick Vieillefond.   

Abstract

In 20 sex-cord tumors of the testes, we investigated immunohistochemistry as a possible method for histopathological diagnosis and evaluation of prognosis. We examined the following molecules: inhibin, CD99, cytokeratin, vimentin, MIB-1, estrogen receptors and progesterone receptors. These tumors of the testes comprised 18 Sertoli cell tumors (ScT) and two undifferentiated sex-cord tumors (USCT). Four tumors have been considered as malignant, because of metastatic spread. Inhibin was expressed by the tumor cells in 80% of sex cord tumors, without any correlation to the degree of differentiation and only in 25% of the malignant cases. Inhibin is a specific marker for sex-cord tumors of the testis and is particularly useful for the diagnosis of USCT. CD99, vimentin, keratin, progesterone and estrogen receptors were expressed in, respectively, 60%, 75%, 35%, 65% and 20% of cases; 95% expressed one of the three following markers: inhibin, CD99 or vimentin. Proliferation index MIB-1 was equal to or higher than 30% in the four malignant cases versus less than 20% in other cases. Lack of inhibin expression and a proliferation index (MIB-1) greater than 30% should be considered as a criterion in favor of malignancy. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15088145     DOI: 10.1007/s00428-004-1017-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  14 in total

1.  [Late metastasis after a testicular Sertoli cell tumour].

Authors:  Eva Compérat; Fréderique Tissier; Annick Vieillefond
Journal:  Ann Pathol       Date:  2004-02       Impact factor: 0.407

2.  Immunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary.

Authors:  D S Arora; I E Cooke; T S Ganesan; J Ramsdale; S Manek; F M Charnock; N P Groome; M Wells
Journal:  J Pathol       Date:  1997-04       Impact factor: 7.996

3.  Differential patterns of inhibin secretion in response to gonadotrophin stimulation in normal men.

Authors:  D Kinniburgh; R A Anderson
Journal:  Int J Androl       Date:  2001-04

4.  Testicular sex cord stromal tumour with granulosa cell differentiation: detection of steroid hormone receptors as a possible basis for tumour development and therapeutic management.

Authors:  W Düe; K P Dieckmann; G Niedobitek; G Bornhöft; V Loy; H Stein
Journal:  J Clin Pathol       Date:  1990-09       Impact factor: 3.411

5.  Inhibin-alpha CD99, HEA125, PLAP, and chromogranin immunoreactivity in testicular neoplasms and the androgen insensitivity syndrome.

Authors:  F Kommoss; E Oliva; F Bittinger; C J Kirkpatrick; M B Amin; A K Bhan; R H Young; R E Scully
Journal:  Hum Pathol       Date:  2000-09       Impact factor: 3.466

6.  Sex cord-stromal tumors of the testis with entrapped germ cells: a lesion mimicking unclassified mixed germ cell sex cord-stromal tumors.

Authors:  T M Ulbright; J R Srigley; V E Reuter; K Wojno; L M Roth; R H Young
Journal:  Am J Surg Pathol       Date:  2000-04       Impact factor: 6.394

7.  Malignant Sertoli cell tumors of the testis: a study of 13 examples of a neoplasm frequently misinterpreted as seminoma.

Authors:  John D Henley; Robert H Young; Thomas M Ulbright
Journal:  Am J Surg Pathol       Date:  2002-05       Impact factor: 6.394

8.  Müllerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors.

Authors:  X Matias-Guiu; C Pons; J Prat
Journal:  Hum Pathol       Date:  1998-08       Impact factor: 3.466

9.  Inhibin B secretion in males with gonadotropin-releasing hormone (GnRH) deficiency before and during long-term GnRH replacement: relationship to spontaneous puberty, testicular volume, and prior treatment--a clinical research center study.

Authors:  L B Nachtigall; P A Boepple; S B Seminara; R H Khoury; P M Sluss; A E Lecain; W F Crowley
Journal:  J Clin Endocrinol Metab       Date:  1996-10       Impact factor: 5.958

10.  Sertoli cell tumors of the testis, not otherwise specified: a clinicopathologic analysis of 60 cases.

Authors:  R H Young; D D Koelliker; R E Scully
Journal:  Am J Surg Pathol       Date:  1998-06       Impact factor: 6.394

View more
  2 in total

Review 1.  Morphological approach to tumours of the testis and paratestis.

Authors:  Robert E Emerson; Thomas M Ulbright
Journal:  J Clin Pathol       Date:  2007-02-16       Impact factor: 3.411

2.  Sex cord-gonadal stromal tumor of the rete testis.

Authors:  Kamran P Sajadi; Rory R Dalton; James A Brown
Journal:  Adv Urol       Date:  2008-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.